{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:28:53Z","timestamp":1793075333919,"version":"4.5.0"},"reference-count":99,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Fail Rev"],"abstract":"<jats:p>There is a large spectrum of acute decompensated heart failure presentations resulting from the interaction between an acute precipitant and the patient\u2019s underlying cardiac and non-cardiac conditions. A robust classification scheme at admission is crucial for appropriate triage and targeted treatment of high-risk populations. Such a scheme should incorporate timely actionable items to generate immediate management decisions, including characteristics that suggest life-threatening clinical presentations, the factors that could be favourably modified by in-hospital interventions, such as correctable aetiologies and congestion\/hypoperfusion status, and in-hospital trajectories determined by patient responses to inpatient treatment. In-hospital trajectories determine the intensity of escalation therapies and timing for initiation\/up-titration of guideline-directed medical treatment. In the long term, some patients experience a progressive downsloping course culminating in advanced heart failure, while others maintain a relatively stable remitting-relapsing trajectory. For future clinical trials, a comprehensive classification scheme integrating in-hospital and long-term trajectories could profoundly affect study design by ensuring interventions are tested in more homogeneous patient populations and facilitating nuanced patient stratification.<\/jats:p>","DOI":"10.15420\/cfr.2025.50","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:22:13Z","timestamp":1778581333000},"source":"Crossref","is-referenced-by-count":3,"title":["A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert Group"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-3628","authenticated-orcid":false,"given":"Ovidiu","family":"Chioncel","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0021gtp06","id-type":"ROR","asserted-by":"publisher"}],"name":"Institutul de Urgen\u0163\u0103 pentru Boli Cardiovasculare \"Prof.Dr. C.C. Iliescu\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-7753","authenticated-orcid":false,"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04q1vy171","id-type":"ROR","asserted-by":"publisher"}],"name":"Marqueurs cardiovasculaires en situation de stress"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-8332","authenticated-orcid":false,"given":"Sean P","family":"Collins","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01c9rqr26","id-type":"ROR","asserted-by":"publisher"}],"name":"VA Tennessee Valley Healthcare System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9613-3339","authenticated-orcid":false,"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04q1vy171","id-type":"ROR","asserted-by":"publisher"}],"name":"Marqueurs cardiovasculaires en situation de stress"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-0253","authenticated-orcid":false,"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02pttbw34","id-type":"ROR","asserted-by":"publisher"}],"name":"Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-9213","authenticated-orcid":false,"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tfzc498","id-type":"ROR","asserted-by":"publisher"}],"name":"Istituti di Ricovero e Cura a Carattere Scientifico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-7064","authenticated-orcid":false,"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01qpw1b93","id-type":"ROR","asserted-by":"publisher"}],"name":"Wroclaw Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4611-8413","authenticated-orcid":false,"given":"Oliviana","family":"Geavlete","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0021gtp06","id-type":"ROR","asserted-by":"publisher"}],"name":"Institutul de Urgen\u0163\u0103 pentru Boli Cardiovasculare \"Prof.Dr. C.C. Iliescu\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-7871","authenticated-orcid":false,"given":"Matteo","family":"Pagnesi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/015rhss58","id-type":"ROR","asserted-by":"publisher"}],"name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-2263","authenticated-orcid":false,"given":"Giuseppe MC","family":"Rosano","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02rwycx38","id-type":"ROR","asserted-by":"publisher"}],"name":"San Raffaele University of Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-2877","authenticated-orcid":false,"given":"Razvan I","family":"Radu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0021gtp06","id-type":"ROR","asserted-by":"publisher"}],"name":"Institutul de Urgen\u0163\u0103 pentru Boli Cardiovasculare \"Prof.Dr. C.C. Iliescu\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-7072","authenticated-orcid":false,"given":"Magdy","family":"Abdelhamid","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03q21mh05","id-type":"ROR","asserted-by":"publisher"}],"name":"Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-1815","authenticated-orcid":false,"given":"Marianna","family":"Adamo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/015rhss58","id-type":"ROR","asserted-by":"publisher"}],"name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4563-1071","authenticated-orcid":false,"given":"Andrew P","family":"Ambrosy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02fxsj090","id-type":"ROR","asserted-by":"publisher"}],"name":"Kaiser Permanente San Francisco Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-2057","authenticated-orcid":false,"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04vfs2w97","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 de Lorraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-8683","authenticated-orcid":false,"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/031t5w623","id-type":"ROR","asserted-by":"publisher"}],"name":"German Centre for Cardiovascular Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-6449","authenticated-orcid":false,"given":"Beth","family":"Davison","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04q1vy171","id-type":"ROR","asserted-by":"publisher"}],"name":"Marqueurs cardiovasculaires en situation de stress"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-7722","authenticated-orcid":false,"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01qpw1b93","id-type":"ROR","asserted-by":"publisher"}],"name":"Wroclaw Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4384-2670","authenticated-orcid":false,"given":"Feras","family":"Bader","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02x4b0932","id-type":"ROR","asserted-by":"publisher"}],"name":"Cleveland Clinic Lerner College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-0852","authenticated-orcid":false,"given":"John","family":"Teerlink","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/049peqw80","id-type":"ROR","asserted-by":"publisher"}],"name":"San Francisco VA Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-9751","authenticated-orcid":false,"given":"Oscar","family":"Miro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021018s57","id-type":"ROR","asserted-by":"publisher"}],"name":"Universitat de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6851-4417","authenticated-orcid":false,"given":"Anika S","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-2869","authenticated-orcid":false,"given":"Mattia","family":"Arrigo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00gkheh82","id-type":"ROR","asserted-by":"publisher"}],"name":"Ospedale regionale di Lugano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0887","authenticated-orcid":false,"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"publisher"}],"name":"Karolinska Institutet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-1738","authenticated-orcid":false,"given":"Tuvia Ben","family":"Gal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01vjtf564","id-type":"ROR","asserted-by":"publisher"}],"name":"Rabin Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5931-1239","authenticated-orcid":false,"given":"G Michael","family":"Felker","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1955-4199","authenticated-orcid":false,"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02qsmb048","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Belgrade"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-7044","authenticated-orcid":false,"given":"Mandeep R","family":"Mehra","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7683-4720","authenticated-orcid":false,"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02teq1165","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Mississippi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-4260","authenticated-orcid":false,"given":"Andrew JS","family":"Coats","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046fa4y88","id-type":"ROR","asserted-by":"publisher"}],"name":"The Heart Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01gmqr298","id-type":"ROR","asserted-by":"publisher"}],"name":"Vita-Salute San Raffaele University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref0","unstructured":"Rosano GMC, Seferovic P, Savarese G, et al. Impact analysis of heart failure across European countries: an ESC-HFA position paper. ESC Heart Fail 2022;9:2767\u201378. https:\/\/doi.org\/10.1002\/ehf2.14076; PMID:\u00a035869679."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Hamo CE, Butler J, Gheorghiade M, Chioncel O. The bumpy road to drug development for acute heart failure. Eur Heart J Suppl 2016;18(Suppl G):G19\u201332. https:\/\/doi.org\/10.1093\/eurheartj\/suw045.","DOI":"10.1093\/eurheartj\/suw045"},{"key":"ref2","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933\u201389. https:\/\/doi.org\/10.1016\/j.ejheart.2008.08.005; PMID:\u00a018826876."},{"key":"ref3","unstructured":"McMurray JJV, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787\u2013847. https:\/\/doi.org\/10.1093\/eurheartj\/ehs104; PMID:\u00a022611136."},{"key":"ref4","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891\u2013975. https:\/\/doi.org\/10.1002\/ejhf.592; PMID:\u00a027207191."},{"key":"ref5","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368; PMID:\u00a034447992."},{"key":"ref6","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023;44:3627\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195; PMID:\u00a037622666."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Cotter G, Biegus J, Fudim M, et al. Acute heart failure care \u2013 a consensus series of an international experts\u2019 group. Eur J Heart Fail 2025;27:3326\u201335. https:\/\/doi.org\/10.1002\/ejhf.70057; PMID:\u00a041015948.","DOI":"10.1002\/ejhf.70057"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mebazaa A, Yilmaz MB, Levy P, et al. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 2015;17:544\u201358. https:\/\/doi.org\/10.1002\/ejhf.289; PMID:\u00a025999021.","DOI":"10.1002\/ejhf.289"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Hollenberg SM, Warner Stevenson L, Ahmad T, et al. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol 2019;74:1966\u20132011. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.001; PMID:\u00a031526538.","DOI":"10.1016\/j.jacc.2019.08.001"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Writing Committee. 2024 ACC expert consensus decision pathway on clinical assessment, management, and trajectory of patients hospitalized with heart failure focused update: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol 2024;84:1241\u201367. https:\/\/doi.org\/10.1016\/j.jacc.2024.06.002; PMID:\u00a039127954.","DOI":"10.1016\/j.jacc.2024.06.002"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Metra M, Tomasoni D, Adamo M, et al. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2023;25:776\u201391. https:\/\/doi.org\/10.1002\/ejhf.2874; PMID:\u00a037208936.","DOI":"10.1002\/ejhf.2954"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ib\u0103nescu R, M\u00ee\u021bu DA, Goje ID, et al. History of heart failure definition. Card Fail Rev 2025;11:e07. https:\/\/doi.org\/10.15420\/cfr.2024.22; PMID:\u00a040171550.","DOI":"10.15420\/cfr.2024.22"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Packer M. Why are physicians so confused about acute heart failure? N Engl J Med 2019;381:776\u20137. https:\/\/doi.org\/10.1056\/NEJMe1904713; PMID:\u00a031433928.","DOI":"10.1056\/NEJMe1904713"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Goode KM, Nabb S, Cleland JGF, Clark AL. A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. J Card Fail 2008;14:379\u201387. https:\/\/doi.org\/10.1016\/j.cardfail.2008.01.014; PMID:\u00a018514929.","DOI":"10.1016\/j.cardfail.2008.01.014"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Butler J, Gheorghiade M, Kelkar A, et al. In-hospital worsening heart failure. Eur J Heart Fail 2015;17:1104\u201313. https:\/\/doi.org\/10.1002\/ejhf.333; PMID:\u00a026235192.","DOI":"10.1002\/ejhf.333"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Gheorghiade M, Shah AN, Vaduganathan M, et al. Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics\u2019, clinicians\u2019, industry\u2019s, regulators\u2019, and payers\u2019 perspectives. Heart Fail Clin 2013;9:. https:\/\/doi.org\/10.1016\/j.hfc.2013.05.002; PMID:\u00a023809415.","DOI":"10.1016\/j.hfc.2013.05.002"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Greene SJ, Fonarow GC, Butler J. Risk profiles in heart failure: baseline, residual, worsening, and advanced heart failure risk. Circ Heart Fail 2020;13:e007132. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007132; PMID:\u00a032482088.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007132"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Cotter G, Davison B. Acute heart failure is a remitting-relapsing disorder and not a step towards advanced heart failure: implications for decongestion therapy. Eur J Heart Fail 2023;25:933\u20135. https:\/\/doi.org\/10.1002\/ejhf.2916; PMID:\u00a037212190.","DOI":"10.1002\/ejhf.2916"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lup\u00f3n J, Gavidia-Bovadilla G, Ferrer E, et al. Heart failure with preserved ejection fraction infrequently evolves toward a reduced phenotype in long-term survivors. Circ Heart Fail 2019;12:e005652. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005652; PMID:\u00a030827137.","DOI":"10.1161\/CIRCHEARTFAILURE.118.005652"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Go YY, Sellmair R, Allen JC Jr, et al. Defining a \u2018frequent admitter\u2019 phenotype among patients with repeat heart failure admissions. Eur J Heart Fail 2019;21:311\u20138. https:\/\/doi.org\/10.1002\/ejhf.1348; PMID:\u00a030549171.","DOI":"10.1002\/ejhf.1348"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hulot JS, Ter Maaten JM, Bayes-Genis A, et al. Heart failure improvement, remission, and recovery: a European Journal of Heart Failure expert consensus document. Eur J Heart Fail 2025;27:1807\u201319. https:\/\/doi.org\/10.1002\/ejhf.3732; PMID:\u00a040533420.","DOI":"10.1002\/ejhf.3732"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Subramaniam AV, Weston SA, Killian JM, et al. Development of advanced heart failure: a population-based study. Circ Heart Fail 2022;15:e009218. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.009218; PMID:\u00a035332793.","DOI":"10.1161\/CIRCHEARTFAILURE.121.009218"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Filippatos G, Angermann CE, Cleland JGF, et al. Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiol 2020;5:401\u201310. https:\/\/doi.org\/10.1001\/jamacardio.2019.5108; PMID:\u00a031913404.","DOI":"10.1001\/jamacardio.2019.5108"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kapoor JR, Kapoor R, Ju C, et al. Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail 2016;4:464\u201372. https:\/\/doi.org\/10.1016\/j.jchf.2016.02.017; PMID:\u00a027256749.","DOI":"10.1016\/j.jchf.2016.02.017"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bezati S, Velliou M, Ventoulis I, et al. Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications. Heart Fail Rev 2023;28:893\u2013904. https:\/\/doi.org\/10.1007\/s10741-023-10303-8; PMID:\u00a036897491.","DOI":"10.1007\/s10741-023-10303-8"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Arrigo M, Gayat E, Parenica J, et al. Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry. Eur J Heart Fail 2017;19:201\u20138. https:\/\/doi.org\/10.1002\/ejhf.682; PMID:\u00a027790819.","DOI":"10.1002\/ejhf.682"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Tavazzi L, Senni M, Metra M, et al. Multicenter prospective observational study on acute and chronic heart failure; one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 2013;6:473\u201381. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000161; PMID:\u00a023476054.","DOI":"10.1161\/CIRCHEARTFAILURE.112.000161"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Butt JH, Fosb\u00f8l EL, Gerds TA, et al. Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort. Eur J Heart Fail 2020;22:1777\u201385. https:\/\/doi.org\/10.1002\/ejhf.1800; PMID:\u00a032227556.","DOI":"10.1002\/ejhf.1800"},{"key":"ref29","unstructured":"Mir\u00f3 \u00d2, Garc\u00eda Sarasola A, Fuenzalida C, et al. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort. Eur J Heart Fail 2019;21:1231\u201344. https:\/\/doi.org\/10.1002\/ejhf.1567; PMID:\u00a031389111."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Chioncel O, Mebazaa A, Harjola VP, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017;19:1242\u201354. https:\/\/doi.org\/10.1002\/ejhf.890; PMID:\u00a028463462.","DOI":"10.1002\/ejhf.890"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Geavlete O, Collins SP, Mebazaa A, et al. Hypertensive acute heart failure: a critical perspective on definition, epidemiology, pathophysiology, and prognosis-a narrative review: a joint session with the Romanian Society of Cardiology (part II). Heart Fail Rev 2025;30:1323\u201340. https:\/\/doi.org\/10.1007\/s10741-025-10551-w; PMID:\u00a040892348.","DOI":"10.1007\/s10741-025-10551-w"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, et al. Acute heart failure congestion and perfusion status \u2013 impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP HFA Heart Failure Long-Term Registry. Eur J Heart Fail 2019;21:1338\u201352. https:\/\/doi.org\/10.1002\/ejhf.1492; PMID:\u00a031127678.","DOI":"10.1002\/ejhf.1492"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Javaloyes P, Mir\u00f3 \u00d2, Gil V, et al. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail 2019;21:1353\u201365. https:\/\/doi.org\/10.1002\/ejhf.1502; PMID:\u00a031127677.","DOI":"10.1002\/ejhf.1502"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Punnoose LR, Gopal DM, Stevenson LW. Time to update our profiles. Eur J Heart Fail 2019;21:1366\u20139. https:\/\/doi.org\/10.1002\/ejhf.1549; PMID:\u00a031321859.","DOI":"10.1002\/ejhf.1549"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Van Aelst LNL, Arrigo M, Placido R, et al. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion. Eur J Heart Fail 2018;20:738\u201347. https:\/\/doi.org\/10.1002\/ejhf.1050; PMID:\u00a029251818.","DOI":"10.1002\/ejhf.1050"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ambrosy AP, Bhatt AS, Gallup D, et al. Trajectory of congestion metrics by ejection fraction in\u00a0patients with acute heart failure (from the Heart Failure \u00a0Network). Am J Cardiol 2017;120:98\u2013105. https:\/\/doi.org\/10.1016\/j.amjcard.2017.03.249; PMID:\u00a028479167.","DOI":"10.1016\/j.amjcard.2017.03.249"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Rosano GMC, Teerlink JR, Kinugawa K, et al. The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS). Eur J Heart Fail 2025;27:1174\u201387. https:\/\/doi.org\/10.1002\/ejhf.3646; PMID:\u00a040260636.","DOI":"10.1002\/ejhf.3646"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Cotter G, Davison B, Biegus J, et al. Increasing evidence supports the benefits of rapid uptitration of the neurohormonal blockade in HFmrEF\/HFpEF patients with AHF. J Card Fail 2025;31:721\u20134. https:\/\/doi.org\/10.1016\/j.cardfail.2024.12.015; PMID:\u00a039947427.","DOI":"10.1016\/j.cardfail.2024.12.015"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Tromp J, Kosiborod MN, Angermann CE, et al. Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction \u2013 results from the EMPULSE trial. Eur J Heart Fail 2024;26:963\u201370. https:\/\/doi.org\/10.1002\/ejhf.3218; PMID:\u00a038572654.","DOI":"10.1002\/ejhf.3218"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Morrow DA, Velazquez EJ, Desai AS, et al. Sacubitril\/valsartan in patients hospitalized with decompensated heart failure. J Am Coll Cardiol 2024;83:1123\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2024.01.027; PMID:\u00a038508844.","DOI":"10.1016\/j.jacc.2024.01.027"},{"key":"ref41","unstructured":"Desai AS, Vaduganathan M, Claggett BL, et al. Finerenone in patients with a recent worsening heart failure event: the FINEARTS-HF trial. J Am Coll Cardiol 2025;85:106\u201316. https:\/\/doi.org\/10.1016\/j.jacc.2024.09.004; PMID:\u00a039352340."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 2022;400:1938\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1; PMID:\u00a036356631.","DOI":"10.1016\/S0140-6736(22)02076-1"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Pagnesi M, Metra M, Cohen-Solal A, et al. Uptitrating treatment after heart failure hospitalization across the spectrum of left ventricular ejection fraction. J Am Coll Cardiol 2023;81:2131\u201344. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.426; PMID:\u00a037257948.","DOI":"10.1016\/j.jacc.2023.03.426"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Biegus J, Mebazaa A, Davison B, et al. Effects of rapid uptitration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF. J Am Coll Cardiol 2024;84:323\u201336. https:\/\/doi.org\/10.1016\/j.jacc.2024.04.055; PMID:\u00a039019527.","DOI":"10.1016\/j.jacc.2024.04.055"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Cotter G, Davison B, Chioncel O. Enhanced decongestive therapy in patients with acute heart failure: JACC review topic of the week. J Am Coll Cardiol 2024;83:1243\u201352. https:\/\/doi.org\/10.1016\/j.jacc.2024.01.029; PMID:\u00a038538204.","DOI":"10.1016\/j.jacc.2024.01.029"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Harjola VP, Parissis J, Bauersachs J, et al. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1298\u2013314. https:\/\/doi.org\/10.1002\/ejhf.1831; PMID:\u00a032347648.","DOI":"10.1002\/ejhf.1831"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Seferovi\u0107 PM, Polovina M, Rosano G, et al. State-of-the-art document on optimal contemporary management of cardiomyopathies. Eur J Heart Fail 2023;25:1899\u2013922. https:\/\/doi.org\/10.1002\/ejhf.2979; PMID:\u00a037470300.","DOI":"10.1002\/ejhf.2979"},{"key":"ref48","unstructured":"Sliwa K, van der Meer P, Petrie MC, et al. Risk stratification and management of women with cardiomyopathy\/heart failure planning pregnancy or presenting during\/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail 2021;23:527\u201340. https:\/\/doi.org\/10.1002\/ejhf.2133; PMID:\u00a033609068."},{"key":"ref49","unstructured":"Chioncel O, Adamo M, Nikolaou M, et al. Acute heart failure and valvular heart disease: a scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. Eur J Heart Fail 2023;25:1025\u201348. https:\/\/doi.org\/10.1002\/ejhf.2918; PMID:\u00a037312239."},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Omerovic E, Citro R, Bossone E, et al. Pathophysiology of takotsubo syndrome \u2013 a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology \u2013 Part 2: Vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail 2022;24:274\u201386. https:\/\/doi.org\/10.1002\/ejhf.2368; PMID:\u00a034655287.","DOI":"10.1002\/ejhf.2390"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Gorenek B, Wijnmaalen AP, Goette A, et al. Ventricular arrhythmias in acute heart failure: a clinical consensus statement of the Association for Acute CardioVascular Care, the European Heart Rhythm Association, and the Heart Failure Association of the European Society of Cardiology. Europace 2024;26:euae235. https:\/\/doi.org\/10.1093\/europace\/euae235; PMID:\u00a039270731.","DOI":"10.1093\/europace\/euae235"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Gualandro DM, Masip J, Halvorsen S, et al. Acute heart failure in non-cardiac surgery. Eur Heart J 2025;46:4042\u201359. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf559; PMID:\u00a040838822.","DOI":"10.1093\/eurheartj\/ehaf559"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Gevaert SA, Halvorsen S, Sinnaeve PR, et al. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias. Eur Heart J Acute Cardiovasc Care 2022;11:865\u201374. https:\/\/doi.org\/10.1093\/ehjacc\/zuac107; PMID:\u00a036226746.","DOI":"10.1093\/ehjacc\/zuac107"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Coles B, Welch CA, Motiwale RS, et al. Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study. Eur Heart J Acute Cardiovasc Care 2023;12:315\u201327. https:\/\/doi.org\/10.1093\/ehjacc\/zuad020; PMID:\u00a036888552.","DOI":"10.1093\/ehjacc\/zuad020"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Steffen HJ, Abel N, Lau F, et al. Timing of acute decompensated heart failure in patients with heart failure and mildly reduced ejection fraction. Heart Vessels 2025;40:592\u2013603. https:\/\/doi.org\/10.1007\/s00380-024-02505-3; PMID:\u00a039841200.","DOI":"10.1007\/s00380-024-02505-3"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Mentz RJ, Felker GM. Noncardiac comorbidities and acute heart failure patients. Heart Fail Clin 2013; 9. https:\/\/doi.org\/10.1016\/j.hfc.2013.04.003; PMID:\u00a023809421.","DOI":"10.1016\/j.hfc.2013.04.003"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Bhatt AS, Ambrosy AP, Dunning A, et al. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial \u2013 insights from ASCEND-HF. Eur J Heart Fail 2020;22:1022\u201331. https:\/\/doi.org\/10.1002\/ejhf.1795; PMID:\u00a032212297.","DOI":"10.1002\/ejhf.1795"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Chioncel O, Benson L, Crespo-Leiro MG, et al. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry. Eur J Prev Cardiol 2023;30:1346\u201358. https:\/\/doi.org\/10.1093\/eurjpc\/zwad151; PMID:\u00a037172316.","DOI":"10.1093\/eurjpc\/zwad151"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"G\u0105secka A, Siniarski A. Addressing \u2018residual congestion\u2019 to improve prognosis after acute heart failure decompensation. Card Fail Rev 2025;11:e06. https:\/\/doi.org\/10.15420\/cfr.2024.24; PMID:\u00a040171551.","DOI":"10.15420\/cfr.2024.24"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Chioncel O, Davison B, Adamo M, et al. Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial. Eur J Heart Fail 2023;25:1994\u20132006. https:\/\/doi.org\/10.1002\/ejhf.3039; PMID:\u00a037728038.","DOI":"10.1002\/ejhf.3039"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Stolfo D, Iacoviello M, Chioncel O, et al. How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Eur J Heart Fail 2025;27:747\u201359. https:\/\/doi.org\/10.1002\/ejhf.3642; PMID:\u00a040091554.","DOI":"10.1002\/ejhf.3642"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Chioncel O, Vinereanu D, Datcu M, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J 2011;162:142\u201353.e1. https:\/\/doi.org\/10.1016\/j.ahj.2011.03.033; PMID:\u00a021742101.","DOI":"10.1016\/j.ahj.2011.03.033"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Spinar J, Parenica J, Vitovec J, et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care 2011;15:R291. https:\/\/doi.org\/10.1186\/cc10584; PMID:\u00a022152228.","DOI":"10.1186\/cc10584"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Logeart D, Isnard R, Resche-Rigon M, et al. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail 2013;15:465\u201376. https:\/\/doi.org\/10.1093\/eurjhf\/hfs189; PMID:\u00a023186936.","DOI":"10.1093\/eurjhf\/hfs189"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Filipescu R, Collins SP, Radu RI, et al. Therapeutic advances in the management of cardiogenic shock. Am J Ther 2026. 33(2):e132\u201345. https:\/\/doi.org\/10.1097\/MJT.0000000000002025; PMID:\u00a041543923.","DOI":"10.1097\/MJT.0000000000002025"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Pagnesi M, Riccardi M, Cotter G, et al. Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management. Heart Fail Rev 2025;30:1559\u201389. https:\/\/doi.org\/10.1007\/s10741-025-10568-1; PMID:\u00a041102558.","DOI":"10.1007\/s10741-025-10568-1"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Harjola VP, Mebazaa A, \u010celutkien\u0117 J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 2016;18:226\u201341. https:\/\/doi.org\/10.1002\/ejhf.478; PMID:\u00a026995592.","DOI":"10.1002\/ejhf.478"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Berrill M, Ashcroft E, Fluck D, et al. Right ventricular dysfunction predicts outcome in acute heart failure. Front Cardiovasc Med 2022;9:911053. https:\/\/doi.org\/10.3389\/fcvm.2022.911053; PMID:\u00a035665249.","DOI":"10.3389\/fcvm.2022.911053"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Viduljevi\u0107 M, Polovina M, Geavlete O, et al. The right approach: power of biomarkers in the assessment and management of right ventricular dysfunction. Int J Mol Sci 2025;26:9064. https:\/\/doi.org\/10.3390\/ijms26189064; PMID:\u00a041009628.","DOI":"10.3390\/ijms26189064"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Gorgis S, Gupta K, Lemor A, et al. Impact of right ventricular dysfunction on outcomes in acute myocardial infarction and cardiogenic shock: insights from the National Cardiogenic Shock initiative. J Card Fail 2024;30:1275\u201384. https:\/\/doi.org\/10.1016\/j.cardfail.2024.07.015; PMID:\u00a039389738.","DOI":"10.1016\/j.cardfail.2024.07.015"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Field ME, Solomon SD, Lewis EF, et al. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. J Card Fail 2006;12:616\u201320. https:\/\/doi.org\/10.1016\/j.cardfail.2006.06.472; PMID:\u00a017045180.","DOI":"10.1016\/j.cardfail.2006.06.472"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Adamopoulos S, Bonios M, Ben Gal T, et al. Right heart failure with left ventricular assist devices: preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2024;26:2304\u201322. https:\/\/doi.org\/10.1002\/ejhf.3323; PMID:\u00a038853659.","DOI":"10.1002\/ejhf.3323"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Okumura N, Jhund PS, Gong J, et al. Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Circulation 2016;133:2254\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020729; PMID:\u00a027143684.","DOI":"10.1161\/CIRCULATIONAHA.115.020729"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Skali H, Dwyer EM, Goldstein R, et al. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT. Eur J Heart Fail 2014;16:560\u20135. https:\/\/doi.org\/10.1002\/ejhf.71; PMID:\u00a024578164.","DOI":"10.1002\/ejhf.71"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Ferreira JP, Metra M, Mordi I, et al. Heart failure in the outpatient versus inpatient setting: findings from the Biostat-CHF study. Eur J Heart Fail 2019;21:112\u201320. https:\/\/doi.org\/10.1002\/ejhf.1323; PMID:\u00a030338883.","DOI":"10.1002\/ejhf.1323"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Greene SJ, Bauersachs J, Brugts JJ, et al. Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week. J Am Coll Cardiol 2023;81:413\u201324. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.023; PMID:\u00a036697141.","DOI":"10.1016\/j.jacc.2022.11.023"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Palazzuoli A, Del Buono MG, La Vecchia G, et al. Worsening versus advanced heart failure: management and challenges. ESC Heart Fail 2025;12:3856\u201368. https:\/\/doi.org\/10.1002\/ehf2.15437; PMID:\u00a041045229.","DOI":"10.1002\/ehf2.15437"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Greene SJ, Butler J. Expanding the definition of worsening heart failure and recognizing the importance of outpatient escalation of oral diuretics. Circulation 2023;148:1746\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066915; PMID:\u00a038011247.","DOI":"10.1161\/CIRCULATIONAHA.123.066915"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Kociol RD, Peterson ED, Hammill BG, et al. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get with the Guidelines \u2013 Heart Failure registry. Circ Heart Fail 2012;5:680\u20137. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.967406; PMID:\u00a022933525.","DOI":"10.1161\/CIRCHEARTFAILURE.112.967406"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Psotka MA, Fonarow GC, Allen LA, et al. The hospital readmissions reduction program: nationwide perspectives and recommendations: a JACC: Heart Failure position paper. JACC Heart Fail 2020;8:1\u201311. https:\/\/doi.org\/10.1016\/j.jchf.2019.07.012; PMID:\u00a031606360.","DOI":"10.1016\/j.jchf.2019.07.012"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Kelly JP, Mentz RJ, Hasselblad V, et al. Worsening heart failure during hospitalization for acute heart failure: insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). Am Heart J 2015;170:298\u2013305. https:\/\/doi.org\/10.1016\/j.ahj.2015.04.007; PMID:\u00a026299227.","DOI":"10.1016\/j.ahj.2015.04.007"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Mentz RJ, Metra M, Cotter G, et al. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. Eur J Heart Fail 2015;17:697\u2013706. https:\/\/doi.org\/10.1002\/ejhf.308; PMID:\u00a026083764.","DOI":"10.1002\/ejhf.308"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Cotter G, Metra M, Davison BA, et al. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the Veritas study. Eur J Heart Fail 2014;16:1362\u201371. https:\/\/doi.org\/10.1002\/ejhf.186; PMID:\u00a025371147.","DOI":"10.1002\/ejhf.186"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Davison BA, Metra M, Cotter G, et al. Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC Heart Fail 2015;3:395\u2013403. https:\/\/doi.org\/10.1016\/j.jchf.2015.01.007; PMID:\u00a025951761.","DOI":"10.1016\/j.jchf.2015.01.007"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Fonseca C, Maggioni AP, Marques F, et al. A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure. Int J Cardiol 2018;250:215\u201322. https:\/\/doi.org\/10.1016\/j.ijcard.2017.10.023; PMID:\u00a029050923.","DOI":"10.1016\/j.ijcard.2017.12.022"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21:137\u201355. https:\/\/doi.org\/10.1002\/ejhf.1369; PMID:\u00a030600580.","DOI":"10.1002\/ejhf.1477"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Chioncel O, Mebazaa A, Farmakis D, et al. Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2025;27:1067\u201388. https:\/\/doi.org\/10.1002\/ejhf.3673; PMID:\u00a040320261.","DOI":"10.1002\/ejhf.3673"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Riccardi M, Pagnesi M, Chioncel O, et al. Medical therapy of cardiogenic shock: contemporary use of inotropes and vasopressors. Eur J Heart Fail 2024;26:411\u201331. https:\/\/doi.org\/10.1002\/ejhf.3162; PMID:\u00a038391010.","DOI":"10.1002\/ejhf.3162"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Felker GM, Ellison DH, Mullens W, et al. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:1178\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.059; PMID:\u00a032164892.","DOI":"10.1016\/j.jacc.2019.12.059"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Iwanek G, Guzik M, Zymli\u0144ski R, et al. Spot urine sodium-to-creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure. ESC Heart Fail 2024;11:3438\u201342. https:\/\/doi.org\/10.1002\/ehf2.14883; PMID:\u00a038855817.","DOI":"10.1002\/ehf2.14883"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Biegus J, Zymli\u0144ski R, Testani J, et al. The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure. Eur J Heart Fail 2023;25:1323\u201333. https:\/\/doi.org\/10.1002\/ejhf.2852; PMID:\u00a037042083.","DOI":"10.1002\/ejhf.2852"},{"key":"ref92","unstructured":"Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419; PMID:\u00a021366472."},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Ter Maaten JM, Beldhuis IE, van der Meer P, et al. Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial. Eur J Heart Fail 2022;24:385\u201392. https:\/\/doi.org\/10.1002\/ejhf.2385; PMID:\u00a034791756.","DOI":"10.1002\/ejhf.2385"},{"key":"ref94","unstructured":"Trull\u00e0s JC, Morales-Rull JL, Casado J, et al. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J 2023;44:411\u201321. https:\/\/doi.org\/10.1093\/eurheartj\/ehac689; PMID:\u00a036423214."},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Mullens W, Dauw J, Martens P, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 2022;387:1185\u201395. https:\/\/doi.org\/10.1056\/NEJMoa2203094; PMID:\u00a036027559.","DOI":"10.1056\/NEJMoa2203094"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Biegus J, Fudim M, Salah HM, et al. Sodium-glucose cotransporter-2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies. Eur J Heart Fail 2023;25:1526\u201336. https:\/\/doi.org\/10.1002\/ejhf.2967; PMID:\u00a037477086.","DOI":"10.1002\/ejhf.2967"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Kap\u0142on-Cie\u015blicka A, Benson L, Chioncel O, et al. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction \u2013 insights from the ESC-HFA EORP Heart Failure Long-Term Registry. Eur J Heart Fail 2022;24:335\u201350. https:\/\/doi.org\/10.1002\/ejhf.2408; PMID:\u00a034962044.","DOI":"10.1002\/ejhf.2408"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Cotter G, Deniau B, Davison B, et al. Optimization of evidence-based heart failure medications after an acute heart failure admission: a secondary analysis of the STRONG-HF randomized clinical trial. JAMA Cardiol 2024;9:114\u201324. https:\/\/doi.org\/10.1001\/jamacardio.2023.4553; PMID:\u00a038150260.","DOI":"10.1001\/jamacardio.2023.4553"}],"container-title":["Cardiac Failure Review"],"original-title":[],"link":[{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2025.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:24:07Z","timestamp":1778581447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2025.50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":99,"URL":"https:\/\/doi.org\/10.15420\/cfr.2025.50","relation":{},"ISSN":["2057-7540","2057-7559"],"issn-type":[{"value":"2057-7540","type":"print"},{"value":"2057-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"e11"}}